Taken together, the IgM glycosylation profile closely correlates with COVID-19 severity on clinical and serological parameters and the cytokines IL-16 and IL-18 may play a role in controlling downstream glycosyltransferase expression in plasma blasts during COVID-19. The gene discussed is CD40LG; the disease is COVID-19.